Mediation effects of diabetes and inflammation on the relationship of obesity to cognitive impairment in African Americans.

Rola Abi Saleh, Seth T Lirette, Emelia J Benjamin, Myriam Fornage, Stephen T Turner, Pamela I Hammond, Thomas H Mosley, Michael E Griswold, B Gwen Windham

Journal: Journal of the American Geriatrics Society 2022;70(10):3021-3029

PMID: 35941823

Abstract

BACKGROUND

Whether diabetes and adipokine-driven inflammation explain the association of obesity to cognitive impairment is unknown.

METHODS

Structural equation models estimated the total effects of waist circumference on cognitive outcomes among African American participants cross-sectionally (index exam) and longitudinally. Total effects were deconstructed into direct pathways of waist circumference to cognitive impairment and indirect mediation pathways through leptin, soluble tumor necrosis factor receptor 2 (sTNFR2), and diabetes. Waist circumference, leptin, and sTNFR2 were standardized. Cognitive impairment was defined as MMSE <21 or a z-score < -1.5 standard deviation (SD). Incident cognitive impairment was defined among those without cognitive impairment at the index exam as follow-up MMSE<21, z- score < -1.5, MMSE decline >1 point/year, or z-score decline of >0.1 SD/year.

RESULTS

Among 1008 participants (70% women, mean age 62.9 years, 14.5% with obesity, 26% with diabetes), 132 (13%) had baseline cognitive impairment. Each SD higher waist circumference was associated with higher odds of cognitive impairment, odds ratio (OR) = 1.63; (95% confidence interval: 1.17, 2.24), with mediating pathways explaining 65% of the total effect (58% from diabetes; 7% from inflammation). At follow-up (mean 6.8 years), 106 of 535 (19.8%) had developed cognitive impairment. Each SD higher waist circumference was associated with higher odds of developing cognitive impairment (OR = 1.87; 95%CI: 1.18, 2.74); the direct effect of waist circumference explained 37% of the total effect and mediating pathways explained 63% (61% from diabetes; 2% from inflammation), although individual pathways were not statistically supported in the smaller sample.

CONCLUSION

Diabetes, and to a lesser degree, adiposity-driven inflammation, appear to explain a substantial proportion of abdominal adiposity relationships with cognitive impairment. The impact of preventing and treating obesity on cognitive outcomes merits study.

© 2022 The American Geriatrics Society.

Address: Department of Medicine, Division of Geriatrics, University of Mississippi Medical Center, Jackson, Mississippi, USA.; Department of Data Science, University of Mississippi Medical Center, Jackson, Mississippi, USA.; Department of Medicine, Boston University School of Medicine and Boston Medical Center, Boston, Massachusetts, USA.; Department of Epidemiology, Boston University School of Public Health, Boston, Massachusetts, USA.; Institute of Molecular Medicine, Health Science Center at Houston, University of Texas, Austin, Texas, USA.; Department of Nephrology, Mayo Clinic, Rochester, Minnesota, USA.; Department of Endocrinology, Diabetes and Nutrition Research, Mayo Clinic, Rochester, Minnesota, USA.
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.